Pavan Asalapuram

Pavan Asalapuram has a diverse work experience in the field of diagnostics and research. Pavan is currently serving as the Chairman of the Board at EMPE Diagnostics Private Limited since 2019. Prior to this, they held various roles at EMPE Diagnostics, including Vice Chairman of the Board of Directors and Vice-CEO/Vice VD. Pavan is also the founder and CEO of EMPE Diagnostics, where they developed a technology for rapid and accurate detection of multi-drug resistant tuberculosis strains.

Apart from their work at EMPE Diagnostics, Pavan has also worked as an Affiliated Researcher at Karolinska Institutet since 2021. In addition, they have experience as a Founder and Chairman at Xact Diagnotek Private Limited, as well as CEO (Managing Director) at EMPE Diagnostics Private Limited, India.

Earlier in their career, Pavan worked as a Researcher and Postdoctoral Researcher at Stockholm University and SciLifeLab. Pavan also served as a Postdoctor at KTH, where they focused on multi-functional recombinant proteins for water treatment, immuno and molecular diagnostics, and assay development. Prior to that, they worked as a Senior Research Fellow at the Centre for Biotechnology, Anna University, Chennai.

Overall, Pavan Asalapuram's work experience showcases their expertise in diagnostic technologies, particularly in the field of tuberculosis detection and drug-resistance profiling.

Pavan Asalapuram has a diverse education history. Pavan began their academic journey at Madras Medical College, College of Pharmacy, Chennai, where they obtained a Bachelor of Pharmacy (B.Pharm.) degree specializing in Pharmaceutical Sciences and Pharmacology. Pavan then pursued an M.S. (by Research) degree in Biotechnology at Anna University. Pavan went on to complete their Ph.D. in Molecular Pathogenesis - Biotechnology from Anna University as well. Pavan later joined Loyola Institute Of Business Administration to study Hospital and Health Care Management. Pavan also engaged in research at Karolinska Institutet, affiliated in the field of Biotechnology and Public Health. Additionally, they served as a Postdoctoral Researcher at Stockholm University, focusing on Molecular Diagnostics.